Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2425–2448 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Head and Neck Cancer, Squamous Cell Carcinoma of the Oral Cavity or Oropharynx, Head and Neck Neoplasms, Carcinoma of the Head and Neck
Interventions: Allovectin-7®; Genetic
Lead sponsor: Vical; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2002
U.S. locations: 10
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Tampa, Florida + 7 more

Conditions: Smoking Cessation
Interventions: Nicotine patch, nicotine inhaler, bupropion, Nicotine patch; Drug
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Tobacco Dependence
Interventions: C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker, Lung Cancer Screening; Behavioral · Drug · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chondral Lesion Plus Partial Medial Meniscectomy
Interventions: Mechanical Debridement, RF-Based Debridement; Device
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 7
States / cities: Tucson, Arizona • Gulf Breeze, Florida • Greenwood, Indiana + 4 more

Conditions: Solitary Pulmonary Nodule, Multiple Pulmonary Nodules
Interventions: Not listed
Lead sponsor: Fresh Medical Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 15
States / cities: Los Angeles, California • San Diego, California • Stanford, California + 12 more

Conditions: Smoking Cessation
Interventions: Distress Tolerance Treatment for Weight Concern (DT-W), Health Education (HE); Behavioral
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Imaged Breast Abnormalities
Interventions: Not listed
Lead sponsor: Intact Medical Corporation; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 24
States / cities: Little Rock, Arkansas • Indio, California • Long Beach, California + 20 more

Conditions: Smoking
Interventions: Tobacco smoking and nicotine patch; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 60 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hidradenitis Suppurativa
Interventions: Intralesional Triamcinolone 10 mg/mL, Intralesional Triamcinolone 20 mg/mL, Intralesional Triamcinolone 40 mg/mL, Placebo; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 13 Years and older
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Coronary Artery Disease
Interventions: Invasive Cardiac Catheterization (ICA), Coronary Computed Tomographic Angiogram (CCTA), Dynamic Cardiac Positron Emission Tomography (dPET); Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 3
States / cities: Atlanta, Georgia • Roslyn, New York

Conditions: Cancer of the Liver, Liver Cancer, Neoplasms, Liver
Interventions: Microwave Ablation; Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 1,254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 14
States / cities: Loma Linda, California • Los Angeles, California • Sacramento, California + 9 more

Conditions: Healthy Volunteers
Interventions: Leuprolide Acetate 3.75, Estradiol, Progesterone, Placebo suppository, Placebo patch; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1994 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Skin Irritancy Potential
Interventions: Chlorhexidine Gluconate, Hibi Universal Bathing System, 0.1% SLS, Distilled Water; Drug · Device · Other
Lead sponsor: Molnlycke Health Care AB; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Enamel Lesions, Caries
Interventions: BlueCheck, Prevident 5000ppm Booster Plus Toothpaste; Device · Drug
Lead sponsor: Colgate Palmolive; Industry
Eligibility: 13 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Lithonia, Georgia

Conditions: Coronary Artery Disease
Interventions: ComboMap XT Guidewire, 'SPY' NIRF During CABG; Device · Procedure
Lead sponsor: East Carolina University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Greenville, North Carolina

Conditions: Cigarette Smoking, Marijuana Abuse
Interventions: bupropion, transdermal nicotine patch, Nicotine polacrilex, nicotine lozenge, counseling for marijuana and smoking cessation, mobile contingency management; Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Peripheral Arterial Disease
Interventions: Laser Atherectomy; Device
Lead sponsor: Spectranetics Corporation; Industry
Eligibility: Not listed
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Houma, Louisiana

Conditions: Hepatocellular Carcinoma
Interventions: liver biopsy, free-breathing MRI; Procedure · Device
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Solid Pancreatic Mass Lesions
Interventions: Suction; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Colonic Polyps
Interventions: non-cathartic CTC; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 50 Years to 80 Years
Enrollment: 605 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 3
States / cities: San Francisco, California • Boston, Massachusetts

Conditions: Central Nervous System Pathology
Interventions: Gadoquatrane (BAY1747846), Gadobutrol (Gadovist/Gadavist); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Chicago, Illinois • Iowa City, Iowa • Hershey, Pennsylvania

Conditions: Psoriasis
Interventions: IDP-118 Lotion; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 4 Years to 17 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 7
States / cities: Doral, Florida • Miami, Florida • Louisville, Kentucky + 4 more

Conditions: Transgenderism, Clotting Disorder
Interventions: Estradiol Tablets, Transdermal patch; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Peripheral Vascular Diseases
Interventions: GORE VIABAHN Endoprosthesis, Bare Nitinol Stent; Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 21 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 15
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Fort Lauderdale, Florida + 12 more

Search by objective public record fields.

Phase II Trial of Allovectin-7® for Head and Neck Cancer

Combination Medications vs. Patch Alone for Medically-Ill Smokers

C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics

Mechanical vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions

A Multi-Center Trial of the ProLung Test™

Women Engaging in Quitting Smoking Together (WE QUIT)

Percutaneous Excision Trial

HIV-1 and Brain Interaction on Smoking Comorbidity

Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa

Quantification of Myocardial Blood Flow Using Dynamic PET/CTA Fused Imagery

NOLA (NeuWave Observational Liver Ablation) Registry

The Effects of Reproductive Hormones on Mood and Behavior

A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations

Enamel Lesion Detection With New DX Tool

Correlation Study of Imaging Data Acquired During CABG With Data Acquired in the Cath Lab

Mobile Contingency Management for Marijuana and Tobacco Cessation

TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions

EUS-FNA With and Without Suction

Evaluation of Computer-assisted, Non-cathartic CT Colonography

Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Coagulation and Fibrinolysis of Estradiol in Transwomen

GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study